510(k) device
Bravo Ph Monitoring System and Accessories
Given Imaging , Ltd. · Electrode, Ph, Stomach (FFT, Class I) · First FDA decision Dec 1, 2010, newest Dec 1, 2010Acid reflux (GERD)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
6
Naming "Bravo Ph"
MAUDE reports
791
Brand "Bravo Ph", since 2015
PubMed studies
90
Mentioning "Bravo Ph"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bravo Ph Monitoring System and Accessories
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K102543 · Decided Dec 1, 2010 · 89 days after receipt
Device type: Electrode, Ph, Stomach (FFT) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Bravo Ph", any status and sponsor, newest update first.
- PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI PatientsNot yet recruiting
University of ChicagoAcademic, hospital or other
NCT07716592 · 80 participants (planned) · Start Dec 2026 · Primary completion Dec 2028
Device: Bravo pH monitoring sessions · For: GERD
Sites: Chicago, Illinois
Guy's and St Thomas' NHS Foundation TrustAcademic, hospital or other
NCT03417817 · 50 participants · Start Oct 16, 2018 · Primary completion Jun 30, 2019
Device: Bravo · For: Gastroesophageal Reflux
Sites: London, United Kingdom · 2 sites in all
- Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its PerformanceCompleted
Medtronic - MITGPublic (MDT)
NCT01503476 · 170 participants · Start Feb 2012 · Primary completion Mar 2016
Device: Bravo® pH Monitoring System; Bravo® pH Monitoring System · For: Gastro Esophageal Reflux Disease
Sites: Jerusalem, Israel
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bravo Ph", and for the whole product code for context.
This brand
791 reports: 697 malfunction, 87 injury, 2 death
Whole product code FFT
6,440 reports: 5,505 malfunction, 909 injury, 4 death
Newest reports for this brand
- Bravo PH SENSORInjury
Medtronic Engineering and Innovation Center (MEIC)
MW6002193 · Received Sep 11, 2026 · Event dated Aug 17, 2026
Device type: Electrode, Ph, Stomach (FFT)
Device problem as coded: Entrapment of Device; Patient-Device Incompatibility
Patient problem as coded: Dysphagia/ Odynophagia
- BRAVO PH CAPSULEInjury
MEDTRONIC ENGINEERING AND INNOVATION CENTER (MEIC)
MW5181802 · Received Jan 6, 2026 · Event dated Oct 23, 2025
Device type: Electrode, Ph, Stomach (FFT)
Patient problem as coded: Foreign Body In Patient
- BRAVO PH CAPSULEMalfunction
22493402 · Received Jul 14, 2025 · Event dated Jan 29, 2025
Device type: Electrode, Ph, Stomach (FFT)
Device problem as coded: Failure to Transmit Record; Incorrect, Inadequate or Imprecise Result or Readings; Device Dislodged or Dislocated; Activation Failure
Patient problem as coded: Low Oxygen Saturation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2047-2025 · Started Jun 3, 2025 · Posted by FDA Jul 10, 2025
Reason given: It has been determined that misapplied adhesive on the Bravo CF capsule delivery device may lead to its malfunction. Specifically, the misapplied adhesive may prevent the capsule from attaching to the patient's esophagus or detaching from the delivery device.
Cause as FDA categorized it: Process control · Device type: Electrode, Ph, Stomach (FFT)
Z-1334-2021 · Started Feb 26, 2021
Reason given: The capsule may fail to attach to the esophageal mucosa, which in turn may lead to the aspiration of the capsule. In the event of capsule aspiration, immediate intervention to remove the capsule is required. Potential outcomes following capsule aspiration include low oxygen saturation, intervention to retrieve the...
Cause as FDA categorized it: Process change control · Device type: Electrode, Ph, Stomach (FFT)
Z-1335-2021 · Started Feb 26, 2021
Reason given: The capsule may fail to attach to the esophageal mucosa, which in turn may lead to the aspiration of the capsule. In the event of capsule aspiration, immediate intervention to remove the capsule is required. Potential outcomes following capsule aspiration include low oxygen saturation, intervention to retrieve the...
Cause as FDA categorized it: Process change control · Device type: Electrode, Ph, Stomach (FFT)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Bravo Ph"[tiab]. The summary above synthesizes these.
- Prolonged pH monitoring: Bravo capsule.
Pandolfino JE, Kahrilas PJ · Gastrointest Endosc Clin N Am · 2005Comparative Study, Research Support, U.S. Gov't, P.H.S.
- The Bravo pH capsule system.
Kwiatek MA, Pandolfino JE · Dig Liver Dis · 2008Review
- Post-POEM reflux: who's at risk?
Arevalo G, Sippey M, Martin-Del-Campo LA, et al. · Surg Endosc · 2020
- Gastroesophageal reflux.
Triadafilopoulos G · Curr Opin Gastroenterol · 2004
- Unreported complication of Bravo pH capsule dislodged into the pyriform sinus.
Kumar A, Kramer E, Chokhavatia S · World J Gastrointest Endosc · 2015
- Correlation of the Endoscopic Gastroesophageal Flap Valve with Pathologic Reflux.
Manasa M, Galvin K, Fazl Alizadeh R, et al. · J Am Coll Surg · 2024
- Muscle Tension Dysphagia: Contributing Factors and Treatment Efficacy.
Kang CH, Zhang N, Lott DG · Ann Otol Rhinol Laryngol · 2021
- Bravura for Bravo pH monitoring.
Triadafilopoulos G · Gastrointest Endosc · 2006Comment, Editorial
- Use and utility of the Bravo pH capsule.
Pandolfino JE, Kwiatek MA · J Clin Gastroenterol · 2008Research Support, Non-U.S. Gov't, Review
- 24 Versus 48-hour bravo pH monitoring.
Chander B, Hanley-Williams N, Deng Y, et al. · J Clin Gastroenterol · 2012Evaluation Study
- Patient adverse events and technical failures with the bravo capsule pH system: insights from the MAUDE database.
Ramai D, Bhandari P, Kewalramani A, et al. · Esophagus · 2023
- Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy.
Ayazi S, Lipham JC, Portale G, et al. · Clin Gastroenterol Hepatol · 2009
Other devices of this type
Also filed under product code FFT.
- Sandhill Scientific Pediatec Ph ProbeSandhill Scientific, Inc. · 510(k) 2002
- Bravo Ph Monitoring SystemEndonetics, Inc. · 510(k) 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.